BanderasNews
Puerto Vallarta Weather Report
Welcome to Puerto Vallarta's liveliest website!
Contact UsSearch
Why Vallarta?Vallarta WeddingsRestaurantsWeatherPhoto GalleriesToday's EventsMaps
 NEWS/HOME
 EDITORIALS
 ENTERTAINMENT
 VALLARTA LIVING
 PV REAL ESTATE
 TRAVEL / OUTDOORS
 HEALTH / BEAUTY
 SALON & SPA SERVICES
 HEALTH FOR WOMEN
 HEALTH FOR MEN
 YOUR WELL BEING
 THE CHALLENGE CORNER
 DENTAL HEALTH
 ON ADDICTION
 RESOURCES
 SPORTS
 DAZED & CONFUSED
 PHOTOGRAPHY
 CLASSIFIEDS
 READERS CORNER
 BANDERAS NEWS TEAM
Sign up NOW!

Free Newsletter!
Puerto Vallarta News NetworkHealth & Beauty 

Vets Get Ecstasy to Treat Their PTSD
email this pageprint this pageemail usKatie Drummond - Danger Room
go to original
September 04, 2010



(U.S Army)
A pair of psychiatric experts think they’ve got the answer to the soaring number of troops coming back from war with PTSD: have them undergo intensive psychotherapy — while they’re rolling on ecstasy.

Dr. Michael Mithoefer and Anne Mithoefer, a psychiatric nurse, are the South Carolina pair who’ve been spearheading research into ecstasy, known clinically as MDMA, since 2000. After one successful study on 21 PTSD patients between 2004 and 2008, they’ve now received the final okay from FDA and DEA officials to start a study entirely devoted to former military service members.

“My sense is that, especially after we published the results of the first study, these institutions are more open to the idea,” Dr. Michael Mithoefer tells Danger Room. “Obviously, this is still new and experimental, and it can take time to get through to big institutions.”

With $500,000 in funding from MAPS (the Multidisciplinary Association for Psychedelic Studies), the two are recruiting 16 veterans — they’re hoping for a 50-50 split between men and women, and want most of the participants to have been diagnosed within the last 10 years.

“These will mostly be veterans from Iraq or Afghanistan, because longer duration of PTSD means more complicating factors,” Dr. Mithoefer says, adding that he does anticipate enrolling 4 vets from earlier wars and is still accepting applications.

Participants will undergo a preliminary screening process, and then partake in three solitary, 8-hour therapy sessions with both doctors. While tripping out, they’ll be asked to revisit the traumatic experiences that triggered their disorder. Dr. Mithoefer thinks MDMA acts as a catalyst for “an optimal zone of arousal” that prevents patients from becoming overwhelmed or, on the flipside, shutting down and detaching altogether.

Of course, the Pentagon’s still struggling to better diagnose and address PTSD, most recently with a cutting edge 72,000 square foot research facility. But despite the military’s gradual thaw on alternative methods to treat the disorder — already, they’ve funded everything from yoga and acupuncture to “Warrior Mind Training” — top brass have yet to endorse MDMA.

“We’re had several conversations with people at Veterans Affairs hospitals and officers at the Department of Defense, but so far haven’t convinced them to participate,” Mithoefer says. “That said, we’re moving forward and still making every effort to get them involved.”

In the meantime, the Mithoefers anticipate finishing this latest study within three years. Teams in Switzerland, Israel, Jordan, Spain and Canada are in various stages of similar research.



In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving
the included information for research and educational purposes • m3 © 2009 BanderasNews ® all rights reserved • carpe aestus